SUMMARY The clinical, radiological, and histological features of two patients with severe intestinal damage induced by mefenamic acid and mimicking coeliac disease are described. Symptoms rapidly reverted on withdrawal of the drug, and in one case, did not relapse during treatment with other non-steroidal anti-inflammatory drugs.
acid1; steatorrhoea due to this drug has been reported in seven patients,2 6 and mild villous damage was observed in the duodenal biopsy specimens of four of these. 34 We report two patients in whom severe villous atrophy and steatorrhoea was apparently due to prolonged treatment with mefenamic acid.
Case report CASE 1 A 66 year old woman had been taking mefenamic acid (250mg four times a day) for 14 years for painful osteoarthritis of the hips and lumbar spine. She had persistent diarrhoea for eight years with a loss of 5 kg of body weight over two years. In 1983 at her local hospital she had been found to have steatorrhoea and villous atrophy. She began a gluten free diet but probably did not strictly adhere to this. She developed a hypochromic microcytic anaemia which did not respond to oral iron treatment but which was corrected by parenteral iron treatment microscopy; villous atrophy with crypt hyperplasia, but no excess of intraepithelial lymphocytes in section. Electron microscopy ( fig 3) showed extensive non-specific brushborder abnormality with clubbed and sparse microvilli, disorganised terminal web, and mitochondrial swelling in enterocytes (fig4).
The mefenamic acid was then withdrawn and within three days diarrhoea stopped. The faecal fat excretion fell to 26 mmol/d, with a daily faecal weight of 221 g. In a repeat jejunal biopsy specimen a return to normal size and shaped villi was seen ( fig 5) and the ultrastructure of enterocytes was normal ( fig 6) . Isaacs, Sladen, Fiipe basal position of the nucleus. In coeliac disease the enterocytes are flattened or polygonal and the regular array of epithelial nuclei is lost. The presence of these features, especially the vacuolation of enterocytes, might provide a clue to the histopathologist that a crypt-hyperplastic villous atrophy might be due to a toxic or drug effect rather than to coeliac disease. The mechanism of the villous damage is not clear. There were no systemic features suggestive of an allergic reaction nor did the patients have atopy, although one patient had a high titre of antinuclear factor. The renal damage associated with this drug7-10 may be due to an interstitial (allergic) nephritis.7 Mefenamic acid has been reported as causing both small bowel inflammation and a colitis mimicking Crohn's disease,4-6 1l and protracted diarrhoea occurring during treatment with mefenamic acid should, therefore, be regarded as a serious side effect and the manu- facturer's instruction that the drug be discontinued strictly adhered to. Notwithstanding the nutritional effects of malabsorption, it has been suggested that the fluid and electrolyte depletion caused by diarrhoea during mefenamic acid treatment may be a major factor contributing to renal failure seen in elderly patients taking this drug.8 Mefenamic acid may also be toxic to the pancreas.10
Steatorrhoea seems to be a side effect unique to mefenamic acid among the non-steroidal antiinflammatory drugs, although case 2 had already had severe diarrhoea and weight loss during treatment with indomethacin. Both this patient and the one patient reported by Chadwick,3 however, were able to continue treatment with another non-steroidal antiinflammatory drug without recurrence of diarrhoea, perhaps suggesting that inhibition of prostaglandin synthesis is not essential to this toxic effect of mefenamic acid." The rapid reversal of the diarrhoea when the drug is withdrawn, in contrast to its slow onset after starting the treatment, has previously been noted,'2 and contrasts with the rapid deleterious effects of non-steroidal anti-inflammatory drugs on ulcerative proctocolitis. l3
The rather small number of reports of steatorroea associated with mefenamic acid might indicate either that the drug was rapidly withdrawn in those patients who developed diarrhoea and who might otherwise have progressed to villous damage, or that the villous damage reflected a specific sensitivity of the jejunal mucosa of a small number of individuals. If the villous atrophy associated with mefenamic acid is an allergic reaction then the study of the mechanism of villous damage induced by mefenamic acid could be of relevance to the pathogenesis of coeliac disease.
Mefenamic acid is of no greater efficacy than aspi- 
